Influenza — CSL H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations
Citation(s)
A Phase II Study in Healthy Adult and Elderly Populations to Assess the Safety and Immunogenicity of an Unadjuvanted CSL H1N1 Influenza Vaccine Administered at Two Dose Levels